RA
DGX icon

Ransom Advisory’s Quest Diagnostics DGX Stock Holding History

Ransom Advisory’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$176K Sell
1,012
-488
-33% -$88.9K 0.07% 135
2025
Q3 		$286K Sell
1,500
-200
-12% -$35.5K 0.13% 95
2025
Q2 		$305K Hold
1,700
– – 0.14% 94
2025
Q1 		$288K Hold
1,700
– – 0.14% 99
2024
Q4 		$256K Sell
1,700
-200
-11% -$31.1K 0.12% 115
2024
Q3 		$295K Sell
1,900
-300
-14% -$44.8K 0.14% 107
2024
Q2 		$301K Sell
2,200
-200
-8% -$27.4K 0.15% 106
2024
Q1 		$319K Buy
+2,400
New +$311K 0.17% 103

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ransom Advisory's DGX Position: Q4 2025 in Review

Ransom Advisory reduced its Quest Diagnostics (DGX) stake by 33% in Q4 2025, selling an estimated $88.9K and leaving 1,012 shares worth $176K. The position accounts for 0.07% of the portfolio, ranked #135.

Ransom Advisory first reported a position in DGX in Q1 2024 and has held it in 8 quarters since. The position peaked at $319K in Q1 2024. 1,049 funds tracked by Wall St. Rank hold DGX as of Q4 2025.

  • Ransom Advisory held 1,012 shares of Quest Diagnostics worth $176K as of Q4 2025.
  • Ransom Advisory sold 488 Quest Diagnostics shares in Q4 2025, an estimated $88.9K.
  • Quest Diagnostics made up 0.07% of Ransom Advisory's portfolio in Q4 2025, its #135 holding.
  • Ransom Advisory first reported a position in Quest Diagnostics in Q1 2024 and has held it in 8 quarters since.
  • Ransom Advisory's Quest Diagnostics position peaked at $319K in Q1 2024.
  • 1,049 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2025.

Based on Ransom Advisory's 13F filing for Q4 2025, filed 6 Jan 2026.